U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
美國司法部通知viatris,不再將邁蘭作爲仿製藥行業反壟斷調查的對象。
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
美國司法部通知viatris,不再將邁蘭作爲仿製藥行業反壟斷調查的對象。
譯文內容由第三人軟體翻譯。